Betzabe Chavez Sanchez

Author

Karolinska Institutet

Also Known As

B Sanchez, B. C. Sanchez, B.C. Sanchez, Betzabe C Sanchez, Betzabe C. Sanchez, Betzabe Chavez Sanchez

Publications

364

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Linköping University Sahlgrenska University Hospital Karolinska University Hospital Science for Life Laboratory

About

Betzabe Chavez Sanchez is an author at Karolinska Institutet specializing in pathology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	98
2	Pathology	3	3	98
3	Cell Biology	1	1	43
4	Cancer Therapeutics	1	1	11
5	Cell Signaling	1	1	43

Betzabe Chavez Sanchez

Publications

363

Citations

H-Index

Page 1

	Year	Citations
An Autocrine VEGF/VEGFR2 and p38 Signaling Loop Confers Resistance to 4-Hydroxytamoxifen in MCF-7 Breast Cancer Cells Reidun Aesöy, Betzabe Chavez Sanchez, Jens Henrik Norum, Molecular Cancer Research	2008	96
Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology Leyre Larzábal, Paul Nguewa, D Blanco, British Journal of Cancer	2011	68
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer Henrik J. Johansson, Betzabe Chavez Sanchez, Filip Mundt, Nature Communications	2013	62
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer Luigi De Petris, Eva Brandén, Richard Herrmann, European Journal of Cancer Prognostic BiomarkersNon-small-cell Lung CancerPlasma LevelsMedicineCytokeratin 18	2010	44
Platelet-Derived Growth Factor Receptor Expression and Activation in Choroid Plexus Tumors Björn Koos, Janna Paulsson, Malin Jarvius, American Journal Of Pathology Choroid Plexus TumorsThrombopoiesisBlood PlateletPathologyChoroid Plexus	2009	43
Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer Henrik J. Johansson, Betzabe Chavez Sanchez, Jenny Forshed, Clinical Proteomics	2015	39
Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF Betzabe Chavez Sanchez, Martina Sundqvist, Helena Fohlin, European Journal of Cancer Prolonged Tamoxifen TreatmentBreast OncologyMedicineCancer RecurrenceRelapse-free Survival	2010	11

Page 1